Nothing Special   »   [go: up one dir, main page]

MX2011006532A - Compuestos anticancerigenos. - Google Patents

Compuestos anticancerigenos.

Info

Publication number
MX2011006532A
MX2011006532A MX2011006532A MX2011006532A MX2011006532A MX 2011006532 A MX2011006532 A MX 2011006532A MX 2011006532 A MX2011006532 A MX 2011006532A MX 2011006532 A MX2011006532 A MX 2011006532A MX 2011006532 A MX2011006532 A MX 2011006532A
Authority
MX
Mexico
Prior art keywords
anticancer compounds
compounds
anticancer
cancer
treatment
Prior art date
Application number
MX2011006532A
Other languages
English (en)
Inventor
Andres Francesch Solloso
Laura Coello Molinero
Jose Fernando Reyes Benitez
Maria Del Carmen Cuevas Marchante
Rogelio Fernandez Rodriguez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MX2011006532A publication Critical patent/MX2011006532A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compuestos de fórmula general I:(ver fórmula (I)) en la que R1-R15 y n adoptan significados permitidos para uso en el tratamiento del cáncer.
MX2011006532A 2008-12-19 2009-12-18 Compuestos anticancerigenos. MX2011006532A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08382080 2008-12-19
PCT/EP2009/067470 WO2010070078A1 (en) 2008-12-19 2009-12-18 Anticancer compounds

Publications (1)

Publication Number Publication Date
MX2011006532A true MX2011006532A (es) 2011-07-13

Family

ID=42046319

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006532A MX2011006532A (es) 2008-12-19 2009-12-18 Compuestos anticancerigenos.

Country Status (12)

Country Link
US (1) US20110237520A1 (es)
EP (1) EP2373678A1 (es)
JP (1) JP2012512839A (es)
KR (1) KR20110096169A (es)
CN (1) CN102256994A (es)
AU (1) AU2009329517A1 (es)
CA (1) CA2745377A1 (es)
IL (1) IL213445A0 (es)
MX (1) MX2011006532A (es)
NZ (1) NZ593169A (es)
RU (1) RU2011129771A (es)
WO (1) WO2010070078A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014108526A1 (en) 2013-01-11 2014-07-17 Pharma Mar, S.A. Synthetic process for the manufacture of pipecolidepsin compounds
US9482052B2 (en) 2013-08-07 2016-11-01 Summer Infant (Usa), Inc. Safety gate with a rewindable, flexible barrier
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Also Published As

Publication number Publication date
IL213445A0 (en) 2011-07-31
AU2009329517A1 (en) 2011-06-23
NZ593169A (en) 2013-07-26
EP2373678A1 (en) 2011-10-12
RU2011129771A (ru) 2013-01-27
CN102256994A (zh) 2011-11-23
JP2012512839A (ja) 2012-06-07
CA2745377A1 (en) 2010-06-24
WO2010070078A1 (en) 2010-06-24
US20110237520A1 (en) 2011-09-29
KR20110096169A (ko) 2011-08-29

Similar Documents

Publication Publication Date Title
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MX360404B (es) Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr.
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
EA201171367A1 (ru) Винилиндазолильные соединения
GEP201706703B (en) Boronate ester compounds and pharmaceutical compositions thereof
MY162146A (en) Pharmaceutical composition
MX342274B (es) Actividades de la piruvato quinasa m2 (pkm2).
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
SG10201811480WA (en) Therapeutic compounds and compositions
IN2012DN02081A (es)
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
MX2009012228A (es) Compuesto de triazolil aminopirimidina.
MX357502B (es) Derivados de pirrolotriazinona.
PH12015501088A1 (en) Dimeric compounds
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
MX336022B (es) Activadores de pkm2 bicíclicos.
MX342947B (es) Tratamiento de diabetes tipo 2.
IL224863B (en) (3,4,5-trimethoxyphenyl)methanone based compounds and uses thereof for the treatment of cancer
MX2014008864A (es) Derivados de triazolo[4,5-d]pirimidina.
MY162934A (en) Anticancer steroidal lactones unsaturated in position 7 (8)
PH12015500399A1 (en) Azaindolines
MY148651A (en) Antitumoral compounds
MX2009012233A (es) Compuestos de triazolil aminopirimidina.
MX2011006532A (es) Compuestos anticancerigenos.

Legal Events

Date Code Title Description
FG Grant or registration